Flow cytometric methods for the assessment of nuclear and chromosomal DNA content and of cell proliferation (including methods based on pulse-chase of bromodeuxyuridine and on monoclonal antibodies against nuclear oncoproteins and proliferation-associated antigens) are illustrated by examples and analyzed critically. The impact of most of these techniques for the study of human solid tumors, with exception of nuclear DNA content evaluation, appears still limited. In particular, new studies of cell lines and clinical material from human tumors using new proliferation markers and multiparameter flow cytometry are necessary to solve a considerable number of methodologic and scientific problems.
Get full access to this article
View all access options for this article.
References
1.
AlitaloK., RamsayG., BishopJ.M., Ohlsson-PfeiferS., ColbyW.W., LevinsonA.D.: Identification of nuclear proteins encoded by viral and cellular myc oncogenesNature, 306: 274–277, 1983.
2.
AndreeffM., AssingG., CirrincioneC.: Prognostic value of DNA/RNA flow cytometry in myeloblastic and lymphoblastic leukemia in adults: RNA content and S-phase predict remission duration and survival in multi-variate analysis. In: AndreeffM. (Ed.), Clinical Cytometry.Annals of the New York Academy of Sciences.New York, U.S.A., 468: 387–406, 1986.
3.
AndreeffM., SlaterD.E., BresslerJ., FurthM.E.: Cellular ras oncogene expression and cell cycle measured by flow cytometry in hematopoietic cell lines.Blood, 67: 676–681, 1986.
4.
AndreeffM.: Flow cytometry of leukemia. In: MelamedM.R., LindmoT., MendelsohnM.L. (Eds.), Flow Cytometry and Sorting.Wiley-Liss, New York, U.S.A., 697–724, 1990.
5.
AtkinN.B., RichardsB.M.: Clinical significance of ploidy in carcinoma of cervix: its relation to prognosis.Br. Med. J., 2: 1445–1446, 1962.
6.
AtkinN.B., KayR.: Prognostic significance of modal DNA value and other factors in malignant tumors, based on 1465 cases.Br. J. Cancer, 40: 210–221, 1979.
BainsM.A., HoyT.G., BainesP., JacobsA.: Nuclear c-myc protein, maturation, and cell-cycle status of human haemopoietic cells.Br. J. Haematol., 67: 293–300, 1987.
9.
BaischH., GöhdeW., LindenW.: Analysis of PCP-data to determine the fraction of cells in the various phases of the cycle.Radiat. Environ. Biophys., 12: 31–37, 1975.
10.
BaischH., GerdesJ.: Simultaneous staining of exponentially growing versus plateau phase cells with the proliferation-associated antibody Ki67 and propidium iodide: analysis by flow cytometry.Cell Tissue Kinet., 20: 387–391, 1987.
11.
BannerB.F., ChachoM.S., RosemanD.L., CoonJ.S.: Multiparameter flow cytometric analysis of colon polyps.Am. J. Clin. Pathol., 87: 313–318, 1987.
12.
BarlogieB., GöhdeW., JohnsonD.A., SmallwoodL., SchumannJ., DrewinkoB., FreireichE.J.: Determination of ploidy and proliferative characteristics of human solid tumors by pulse cytophotometry.Cancer Res., 8: 3333–3339, 1978.
13.
BarlogieB., RaberM.N., SchumannJ., JohnsonT.S., DrewinkoB., SwartzendruberD.E., GöhdeW., AndreeffM., FreireichE.J.: Flow cytometry in clinical cancer research.Cancer Res., 43: 3982–3997, 1983.
14.
BarnabeiV.M., MillerD.S., BauerK.D., MuradT.M., RademakerA.W., LurainJ.R.: Flow cytometric evaluation of epithelial ovarian cancer.Am. J. Obstet. Gynecol., 162: 1584–1590, 1990.
15.
BauerK.D., ClevengerC.V., EndowR.K., MuradT., EpsteinA.L., ScarpelliD.G.: Simultaneous nuclear antigen and DNA content quantitation using paraffin-embedded colonic tissue and multiparameter flow cytometry.Cancer Res., 46: 2428–2434, 1986.
16.
BauerK.D., LincolnS.T., Vera-RomanJ.M., WallermarkC.B., ChmielJ.S., MadurskiM.L., MuradT., ScarpelliD.G.: Prognostic implications of proliferative activity and DNA aneuploidy in colonic adenocarcinomas.Lab. Invest., 57: 329–335, 1987.
17.
BawaniM., TibrewalaS., CopurS., HarrisD., Gilman-SachsA.: DNA flow cytometry of colorectal carcinoma: correlation of DNA stemlines with other prognostic indices.Am. J. Gastroenterol., 86: 191–195, 1991.
18.
BeermanH., KluinP.M., HermansJ., van de VeldeC.J., CornelisseC.J.: Prognostic significance DNA-ploidy in a series of 690 primary breast cancer patients.Int. J. Cancer, 45: 34–39, 1990.
19.
BeggA.C., McNallyN.J., ShrieveD.C., KaercherH.: A method to measure the duration of DNA synthesis and the potential doubling time from a single sample.Cytometry, 6: 620–626, 1985.
20.
BeiskerW., DolbeareF., GrayJ.W.: An improved procedure for BrdU/DNA analysis: high sensitivity detection of BrdU.Cytometry, 8: 235–239, 1987.
21.
BensonM.C., McDougalD.C., CoffeyD.S.: The application of perpendicular and forward light scatter to assess nuclear and cellular morphology.Cytometry, 5: 515–522, 1984.
22.
BensonM.C., RingK., GiellaJ.: Flow cytometry in carcinoma of the prostate.Urol. Clin. North Am., 17: 885–891, 1990.
BjelkenkrantzK., LundgrenJ., OlofssonJ.: Single-cell DNA measurement in hyperplastic, dysplastic and carcinomatous laryngeal epithelia, with special reference to the occurrence of hypertetraploid cell nuclei.Anal. Quant. Cytol., 5: 184–188, 1983.
25.
BorkjeB., HostmarkJ., SkagenD.W., SchrumpfE., LaerumO.D.: Flow cytometry of biopsy specimens from ulcerative colitis, colorectal adenomas, and carcinomas.Scand. J. Gastroenterol., 22: 1231–1237, 1987.
26.
BoveriT.: Zur Frage der Entstehung maligner Tumoren.Verlag von Gustav Fischer, Jena, Germany, 1914.
27.
BravoR., Macdonald-BravoH.: Existence of two populations of cyclin/proliferating cell nuclear antigen during the cell cycle: Association with DNA replication sites.J. Cell Biol., 105: 1549–1554, 1986.
28.
BravoR., FrankR., BlundellP.A., Macdonald-BravoH.: Cyclin-PCNA is the auxiliary protein of DNA polymerase-δ.Nature, 326: 515–517, 1987.
29.
BraylanR.C., DiamondL.W., PowellM.L., Harty-GolderB.: Percentage of cells in the S-phase of the cell cycle in human lymphoma determined by flow cytometry: Correlation with labeling index and patient survival.Cytometry, 1: 171–174, 1980.
30.
BresciaR.J., BarakatR.A., BellerU., FredericksonG., SuhrlandM.J., DubinN., DemopoulosR.I.: The prognostic significance of nuclear DNA content in malignant epithelial tumors of the ovary.Cancer, 65: 141–147, 1990.
31.
BrunoS., Di VinciA., GeidoE., GiarettiW.: Cell cycle synchronization induced by tamoxifen and 17-β-estradiol on MCF-7 cells using flow cytometry and a monoclonal antibody against bromodeoxyuridine.Breast Cancer Res. Treat., 11: 221–230, 1988.
32.
CairnsJ.: The origin of human cancers.Nature, 289: 353–357, 1981.
33.
CarateroC., HijaziA., CarateroA., MazerollesC., RischmannP., SarramonJ.P.: Flow cytometry analysis of urothelial cell DNA content according to pathological and clinical data on 100 bladder tumors.Eur. Urol., 18: 145–149, 1990.
34.
CarranoA.V., Van DillaM.A., GrayJ.W.: Flow cytogenetics: A new approach to chromosome analysis. In: MelamedM.R., MullaneyP.F., MendelsohnM.L. (Eds.), Flow Cytometry and Sorting.John Wiley & Sons, New York, U.S.A., 421–451, 1979.
35.
CelisJ.E., BravoR., LarsenP.M., FeyS.J.: Cyclin: A nuclear protein whose level correlates directly with the proliferative state of normal as well as transformed cells.Leukemia Res., 8: 143–157, 1984.
36.
CelisJ.E., FeyS.J., LarsenP.M., CelisA.: Expression of the transformation-sensitive protein « cyclin » in normal human epidermoid basal cells and Simian virus 40-transformed keratinocytes.Proc. Natl. Acad. Sci. USA, 81: 3128–3132, 1984.
37.
ChangC., SimmonsD.T., MartinM.A., MoraP.T.: Identification and partial characterization of new antigens from simian virus (SV40) transformed mouse cells.J. Virol., 31: 463–470, 1979.
ChristovK., VassilevN.: Flow cytometry analysis of DNA and cell proliferation in ovarian tumors.Cancer, 60: 121–125, 1987.
40.
ClarkG.M., DressierL.G., OwensM.A., PoundsG., OldakerT., McGuireW.L.: Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry.N. Engl. J. Med., 320: 627–633, 1989.
41.
ClevengerC.V., EpsteinA.L., BauerK.D.: Modulation of the nuclear antigen p105 as a function of cell-cycle progression.J. Cell. Physiol., 130: 336–343, 1987.
42.
ClevengerC.V., EpsteinA.L., BauerK.D.: Quantitative analysis of a nuclear antigen in interphase and mitotic cells.Cytometry, 8: 280–286, 1987.
43.
CoonJ.S., LandayA.L., WeinsteinR.S.: Advances in flow cytometry for diagnostic pathology.Lab. Invest., 57: 453–479, 1987.
44.
CornelisseC.J., Van De VeldeC.J.H., CaspersR.J.C., MoolenaarA.J., HermansJ.: DNA ploidy and survival in breast cancer patients.Cytometry, 8: 225–234, 1987.
45.
CostaA., MazziniG., DelBinoG., SilvestriniR.: DNA content and proliferative characteristics of non-Hodgkin's lymphomas determined by flow cytometry.Cytometry, 2: 185–190, 1981.
46.
CoxD.R.: Regression models and life tables.J. R. Stat. Soc., B 34; 187–220, 1972.
47.
CrissmanH.A., SteinkampJ.A.: Cytochemical techniques for multivariate analysis of DNA and other cellular constituents. In: MelamedMR., LindmoT., MendelsohnM.L. (Eds.), Flow Cytometry and Sorting.Wiley-Liss, New York, U.S.A., 227–248, 1990.
48.
CusickE.L., MiltonJ.I., EwenS.W.B.: The resolution of aneuploid DNA stem lines by flow cytometry: limitations imposed by the coefficient of variation and the percentage of aneuploid nuclei.Anal. Cell. Pathol., 2: 139–148, 1980.
49.
DanovaM., RiccardiA., GaetaniP., WilsonG., MazziniG., BrugnatelliS., ButtiniR., ButtiG., UcciG., PaolettiP., AscariE.: Cell kinetics of human brain tumors: In Vivo study with bromodeoxyuridine and flow cytometry.Eur. J. Cancer Clin. Oncol., 24: 873–880, 1988.
50.
DanovaM., RiccardiA., BrugnatelliS., FiocccaR., GirinoM., VillaniL., GiordanoP., DionigiP., GiordanoM., ButtiniR., UcciG., MazziniG.: In vivo bromodeoxyuridine incorporation in human gastric cancer: a study on formalin-fixed and paraffin-embedded sections.Histochem. J., 20: 125–130, 1988.
51.
DanovaM., GiarettiW., MerloF., MazziniG., GeidoE., GaetaniP., GentileS., ButtiG., Di VinciA., RiccardiA.: Prognostic significance of nuclear DNA content in human neuroepithelial tumors.Int. J. Cancer, 48: 663–667, 1991.
52.
DarzynkiewiczZ., TraganosF., SharplessT., MelamedM.R.: Thermally-induced changes in chromatin of isolated nucleic acids and of intact cells as revealed by acridine orange staining.Biochem. Biophys. Res. Common., 59: 392–399, 1974.
53.
DarzynkiewiczZ., TraganosF., SharplessT., MelamedM.R.: Different sensitivity of DNA in situ in interphase and metaphase chromatin to heat denaturation.J. Cell Biol., 73: 128–138, 1977.
54.
DarzynkiewiczZ., TagranosF., MelamedM.R.: New cell cycle compartments identified by multiparameter flow cytometry.Cytometry, 1: 98–108, 1980.
55.
DarzynkiewiczZ., TraganosF., MelamedM.R.: Distinction between 5-bromodeoxyuridine labelled and unlabelled mitotic cells by flow cytometry.Cytometry, 3: 345–348, 1983.
56.
DarzynkiewiczZ., TraganosF., KapuscinskiJ., MelamedM.R.: Denaturation and condensation of DNA in situ induced by acridine orange.Relationship to chromatin changes during differentiation of Friend erythroleukemic cells. Cytometry, 6: 195–207, 1985.
57.
DarzynkiewiczZ., Staiano-CoicoL., KunickaJ.E., DeLeoA.B., OldL.J.: p53 content in relation to cell growth and proliferation in murine L1210 leukemia ad normal lymphocytes.Leuk. Res., 10: 1383–1389, 1986.
58.
DarzynkiewiczZ.: Cytochemical probes of cycling and quiescent cells applicable to flow cytometry. In: GrayJ.W., DarzynkiewiczZ. (Eds.), Techniques in Cell Cycle Analysis.Humana Press, Clifton, New Jersey, 255–290, 1987.
59.
DarzynkiewiczZ.: Flow cytometry in cytopathology: overview and perspectives.Anal. Quant. Cytol. Histol., 10: 459–461, 1988.
60.
DarzynkiewiczZ., KapuscinskiJ.: Acridine orange: a versatile probe of nucleic acids and other cell constituents. In: MelamedM., LindmoT., MendelsohnM.L. (Eds.), Flow Cytometry and Sorting.Wiley-Liss, New York, U.S.A., 291–314, 1990.
61.
DarzynkiewiczZ., TraganosF.: Multiparameter flow cytometry in studies of the cell cycle. In: MelamedM.R., LindmoT., MendelsohnM.L. (Eds.), Flow Cytometry and Sorting.Wiley-Liss, New York, U.S.A., 469–502, 1990.
62.
DavisD., Wyndford-ThomasD.: Heterogeneity in distribution and content of p53 in SV40-transformed mouse fibroblasts.Exp. Cell Res., 166: 94–102, 1986.
63.
DeanP.N., JettJ.H.: Mathematical analysis of DNA distributions derived from flow microfluorometry.J. Cell Biol., 60: 523–527, 1974.
64.
DeanP.N., DolbeareF., GratznerH., RiceG., GrayJ.W.: Cell-cycle analysis using a monoclonal antibody to BrdU.Cell Tissue Kinet., 17: 427–436, 1984.
65.
DeanP.N.: Methods of data analysis in flow cytometry. In: Van DillaM.A., DeanP.N., LaerumO.D., MelamedM.R. (Eds.), Flow Cytometry: Instrumentation and Data Analysis.Academic Press, London, New York, Tokyo, 195–211, 1985.
66.
DeanP.N.: Data analysis in cell kinetics research. In: GrayJ.W., DarzynkiewiczZ. (Eds.), Techniques in Cell Cycle Analysis.Humana Press, Clifton, New Jersey, 207–253, 1987.
67.
De LeoA.B., JayG., ApeliaE., DuboisG.C., LawI.W., OldL.J.: Detection of a transformation-related antigen in chemically-induced sarcomas and other transformed cells of the mouse.Proc. Natl. Acad. Sci. USA, 76: 2420–2426, 1979.
68.
DentG.A., AyscueL.H., HighK.A., LegliseM.C., RossD.W.: Flow cytometric correlation of the c-myc oncoprotein and cell cycle kinetics of HL60 leukemia during induced maturation with cytosine arabinoside and dimethylsulphoxide.Cell Tissue Kinet., 22: 1–11, 1989.
69.
De VitaR., CalugiA., MaggiF., MauroF., MontevecchiL., VecchioneA.: Flow cytometric DNA analysis of the human cervix affected by human papillomavirus and/or intraepithelial neoplasia.Anal. Quant. Cytol. Histol., 12: 306–313, 1990.
70.
De VitaR., ForteD., MaggiF., EleuteriP., Di SilverioF.: Cellular DNA content and proliferative activity evaluated by flow cytometry versus histopathological and staging classifications in human bladder tumors.Eur. Urol., 19: 65–73, 1991.
71.
DolbeareF.A., GratznerH.G., PallaviciniM.G., GrayJ.W.: Flow cytometric measurement of total DNA content and incorporated bromodeoxyuridine.Proc. Natl. Acad. Sci. USA, 80: 5573–5577, 1983.
72.
DolbeareF., BeiskerW., PallaviciniM.G., VanderlaanM., GrayJ.W.: Cytochemistry for BrdU/DNA analysis: Stoichiometry and sensitivity.Cytometry, 6: 521–530, 1985.
73.
DormerP.: Morphometry and cytometry correlated to quantitative autoradiography.Anal. Quant. Cytol. Histol., 9: 115–122, 1987.
74.
DouglasE.M., DressierL.G., McGuireW.L.: Flow cytometry, cellular DNA content, and prognosis in human malignancy.J. Clin. Oncol., 5: 1690–1703, 1987.
75.
DrukerB.J., MamonH.J., RobertsJ.M.: Oncogenes, growth factors, and signal transduction.N. Engl. J. Med., 321: 1383–1391, 1989.
76.
EliyahuD., RazA., GrussD., GivolD., OrenM.: Participation of p53 cellular tumor antigen in transformation of normal embryonic cells.Nature, 312: 646–649, 1984.
77.
el NaggarA.K., OrdonezN.G., McLemoreD., SchultzP., HickeyR.C., SamaanN.: Clinicopathologic and flow cytometric DNA study of medullary thyroid carcinoma.Surgery, 108: 981–985, 1990.
78.
el NaggarA.K., OrdonezN.G., SaraA., McLemoreD., BatsakisJ.G.: Clear cell sarcomas and metastatic soft tissue melanomas.A flow cytometric comparison and prognostic implications. Cancer, 67: 2173–2179, 1991.
79.
EmdinS.O., StenlingR., GoranR.: Prognostic value of DNA content in colorectal carcinoma.A flow cytometric study with some methodological aspects. Cancer, 60: 1282–1287, 1987.
80.
EngelhardH.H.III, KrupkaJ.L., BauerK.D.: Simultaneous quantification of c-myc oncoprotein, total cellular protein, and DNA content using multiparameter flow cytometry.Cytometry, 12: 68–76, 1991.
81.
ErbaE., VaghiM., PepeS., AmatoG., BistolfiM., UbezioP., MangioniC., LandoniF., MorascaL.: DNA index of ovarian carcinomas from 56 patients: in vivo in vitro studies.Br. J. Cancer, 52: 565–573, 1985.
82.
EvanG.I., LewisG.K., RamsayG., BishopJ.M.: Isolation of monoclonal antibodies specific for human c-myc protooncogene product.Mol. Cell. Biol., 5: 3610–3616, 1985.
83.
FalleniusA.G., FranzenS.A., AuerG.U.: Predictive value of nuclear DNA content in breast cancer in relation to clinical and morphologic factors.Cancer, 62: 521–530, 1988.
84.
FannertyM.B., SamplinerR.E., WayD., RiddellR., SteinbronnK., GarewalH.S.: Discordance between flow cytometric abnormalities and dysplasia in Barrett's esophagus.Gastroenterology, 97: 815–820, 1989.
85.
FearonE.R., VogelsteinB.: A genetic model for colorectal tumorogenesis.Cell, 61: 759–767, 1990.
86.
FeitzW.F.J., BeckH.L.M., SmeetsA.W.G.B., DebruyneF.M.J., VooijsG.P., HermanC.J., RamaekersF.C.S.: Tissue-specific markers in flow cytometry of urological cancers: cytokeratins in bladder carcinoma.Int. J. Cancer, 36: 349–356, 1985.
87.
FeramiscoJ.R., GrossM., KamataT., RosenbergM., SweetR.W.: Microinjection of the oncogene form of the human H-ras (T-24) protein results in rapid proliferation of quiescent cells.Cell, 38: 109–112, 1984.
88.
FreedmanD., AuerspergN.: Detection of an intracellular transforming protein (v-Ki-ras-p21) using the flow activated, cell sorter (FACS).Vitro Cell. Develop. Biol., 22: 621–622, 1986.
89.
FriedlanderM.L., HedleyD.W., TaylorI.W.: Clinical and biological significance of aneuploidy in human tumors.J. Clin. Pathol., 37: 961–974, 1984.
90.
FriedlanderM.L., HedleyD.W., SwansonC.: Prediction of long-term survivaly by flow cytometric analysis of cellular DNA content in patients with advanced ovarian cancer.J. Clin. Oncol., 6: 282–290, 1988.
91.
FriersonH.F.: Flow cytometric analysis of ploidy in solid neoplasms: comparison of fresh tissue with formalin-fixed paraffin-embedded specimens.Human Pathol., 19(3): 290–294, 1988.
92.
FriesorH.F.Jr.: Ploidy analysis and S-phase fraction determination by flow cytometry of invasive adenocarcinomas of the breast. Am. J. Surg.Pathol., 15(4): 358–367, 1991.
93.
GeidoE., GiarettiW., NüsseM.: Detection of M and early-G1 phase cells by scattering signals combined with identification G1, S, and G2 phase cells. In: DarzynkiewiczZ., CrissmanH.A. (Eds.), Methods in Cell Biology. Vol. 33 Flow Cytometry.Academic Press, New York, U.S.A., 149–156, 1990.
94.
GerdesJ., SchwabU., LemkeH., SteinH.: Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation.Int. J. Cancer, 31: 13–17, 1983.
95.
GerdesJ., LemkeH., BaisCh.H., WackerH.H., SchwabU., SteinH.: Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki67.J. Immunol., 133: 1710–1715, 1984.
96.
GiarettiW., AbmayrW., DörmerP.: Multiparameter nuclear morphology of the G0-G1 transition.Anal. Quant. Cytol., 5: 90–98, 1983.
97.
GiarettiW., GaisP., JüttingU., RodenackerK., DörmerP.: Correlation between chromatin morphology as derived by digital image analysis and autoradiographic labeling pattern.Anal. Quant. Cytol., 5: 79–89, 1983.
98.
GiarettiW., AbmayrW., DörmerP., SantiL.: The G0-G1 transitions of human lymphocytes as monitored by quantitative 14C-uridine autoradiography and high-resolution image analysis.Cytometry, 6: 219–225, 1985.
99.
GiarettiW., ScialleroS., BrunoS., GeidoE., AsteH., Di VinciA.: DNA flow cytometry of endoscopically examined colorectal adenomas and adenocarcinomas.Cytometry, 9: 238–244, 1988.
100.
GiarettiW., MoroG., QuartoR., BrunoS., Di VinciA., GeidoE., CanceddaR.: Flow cytometric evaluation of cell cycle characteristics during in vitro differentiation of chick embryo chondrocytes.Cytometry, 9: 281–290, 1988.
101.
GiarettiW., ScialleroS., BrunoS., GeidoE., AsteH., Di VinciA., d'AmoreE.S.G.: DNA flow cytometry of endoscopically examined colorectal adenocarcinomas.Pathol. Res. Pract., 185: 589–593, 1989.
102.
GiarettiW., NüsseM., BrunoS., Di VinciA., GeidoE.: A new method to discriminate G1, S, G2, M and G1-postmitotic cells.Exp. Cell Res., 182: 290–295, 1989.
103.
GiarettiW., SantiL.: Tumor progression by DNA flow cytometry in human colorectal cancer.Int. J. Cancer, 45: 597–603, 1990.
104.
GiarettiW., Di VinciA., GeidoE., MarsanoB., MinksM., BrunoS.: Measurement of c-myc protein content and cell cycle kinetics of normal and spontaneously transformed murine mastocytes by bivariate flow cytometry.Cell Tissue Kinet., 23: 473–485, 1990.
105.
GiarettiW., DanovaM., GeidoE., MazziniG., ScialleroS., AsteH., ScivettiP., RiccardiA., MerloF., d'AmoreE.S.G.: DNA flow cytometry in prognosis of colorectal cancer.Cancer, 67: 1921–1927, 1991.
106.
GiordanoM., DanovaM., RiccardiA., MazziniG.: Simultaneous detection of cellular ras p21 oncogene product and DNA content by two parameter flow cytometry.Anticancer Res. (in press).
107.
GohH.S., JassJ.R.: DNA content and the adenoma-carcinoma sequence in the colorectum.J. Clin. Pathol., 39: 387–392, 1986.
108.
GöhdeW., SchumanJ., ZanteJ.: The use of DAPI in pulse cytophotometry. In: LutzD. (Ed.), Pulse Cytophotometry, Ghent, Belgium, 229–232, 1978.
109.
GratznerH.: Monoclonal antibody against 5-bromo-and 5-iododeoxyuridine.A new reagent for detection of DNA replication. Science, 218: 474–475, 1982.
110.
GrayJ.W., LangloisR.G., CarranoA.V., Burkhart-SchultzK., Van DillaM.A.: High resolution chromosome analysis: One and two parameter flow cytometry.Chromosoma, 73: 9–27, 1979.
111.
GrayJ.W.: Quantitative cytokinetics: Cellular response to cell cycle specific agents.Pharmacol. Ther., 22: 163–197, 1983.
112.
GrayJ.W., LangloisR.G.: Chromosome classification and purification using flow cytometry and sorting.Annu. Rev. Biophys. Chem., 15: 195–235, 1986.
GrayJ.W., CramL.S.: Flow karyotyping and chromosome sorting. In: MelamedM.R., LindmoT., MendelsohnM.L. (Eds.), Flow Cytometry and Sorting.Wiley-Liss, New York, U.S.A., 503–530, 1990.
115.
GrayJ.W., DolbeareF., PallaviciniM.G.: Quantitative cell-cycle analysis. In: MelamedM.R., LindmoT., MendelsohnM.L. (Eds.), Flow Cytometry and Sorting.Wiley-Liss, New York, U.S.A., 445–468, 1990.
116.
GreenD.K., FantesJ.A., BucktonK.E., ElderJ.K., MalloyP., CarothersA., EvansH.J.: Karyotyping and identification of human chromosome polymorphism by single fluorochrome flow cytometry.Hum. Genet., 66: 143–146, 1984.
117.
GriepA.E., WestphalH.: Antisense myc sequences induce differentiation of F9 cells.Proc. Natl. Acad. Sci. USA, 85: 6806–6810, 1988.
118.
HagagN., DiamondL., PalermoR., LyubskyS.: High expression of ras p21 correlates with increased rate of abnormal mitosis in NIH3T3 cells.Oncogene, 5: 1481–1489, 1990.
119.
HamaguchiK., NishimuraH., MiyoshiT., MiyaharaK., TatenoN., YakushijiM., YokoyamaM.M.: Flow cytometric analysis of cellular DNA content in ovarian cancer.Gynecol. Oncol., 37: 219–223, 1990.
120.
HammarbergC., SlezakP., TribukaitB.: Early detection of malignancy in ulcerative colitis: a flow-cytometric DNA study.Cancer, 53: 291–295, 1984.
121.
HedleyD.W.: Flow cytometry using paraffin-embedded tissue: five years on.Cytometry, 10: 229–241, 1989.
122.
HeikkilaR., SchwabG., WickstromE., LokeS.L., PluznikD.H., WattR., NeckersL.M.: A c-myc antisense oligodeoxynucleotide inhibits entry into S-phase but not progress from G0 to G1.Nature, 328: 445–449, 1987.
123.
HeimannT.M., MillerF., MartinelliG., MesterJ., KurtzR.J., SzpornA., FasyT.: Significance of DNA content abnormalities in small rectal cancers.Am. J. Surg., 159: 199–202, 1990.
124.
HeliöH., KaraharjuE., NordlingS.: Flow cytometric determination of DNA content in malignant and benign bone tumors.Cytometry, 6: 165–171, 1985.
125.
HemmerJ., SchonE., KreidlerJ., HaaseS.: Prognostic implications of DNA ploidy in squamous cell carcinomas of the tongue assessed by flow cytometry.J. Cancer Res. Clin. Oncol., 116: 83–86, 1990.
126.
Hendy-IobsP., CoxH., EvanG.I., WatsonJ.V.: Flow cytometric quantitation of DNA and c-myc oncoprotein in archival biopsies of uterine cervix neoplasia.Br. J. Cancer, 55: 275–282, 1987.
127.
HiddemannW., SchumannJ., AndreeffM., BarlogieB., HermanC.J., LeifR.C., MayallB.H., MurphyR.F., SandbergA.A.: Convention on nomenclature for DNA cytometry.Cancer Genet. Cytogenet., 13: 181–183, 1984.
128.
HiddemannW., Von BassewitzD.B., KleinemeierH.J., Schulte-BrochterbeckE., HaussJ., LingemannB., BüchnerT., GrundmannE.: DNA stemline heterogeneity in colorectal cancer.Cancer, 58: 258–263, 1986.
129.
HiebertR.D.: Electronics and signal processing. In: MelamedM.R., LindmoT., MendelsohnM.L. (Eds.), Flow Cytometry and Sorting.Wiley-Liss, New York, U.S.A., 127–144, 1990.
130.
HoffmanR.A., KungP.C., HansenW.P., GoldsteinG.: Simple and rapid measurement of human T lymphocytes and their subclasses in peripheral blood.Proc. Natl. Acad. Sci. USA, 77: 4914–4917, 1980.
131.
HoshinoT., NagashimaT., ChoK.G., MurovicJ.A., HodesJ.E., WilsonC.B., EdwardsM.S.B., PittisL.H.: S-phase fraction of human brain tumors in situ measured by uptake of bromodeoxyuridine.Int. J. Cancer, 38: 369–374, 1986.
132.
HoshinoT., NagashimaT., MurovicJ.A., WilsonC.B., DavisR.L.: Proliferative potential of human meningiomas of the brain: a cell kinetics study with bromodeoxyuridine.Cancer, 58: 1466–1472, 1986.
133.
IsolaJ., KallioniemiO.P., KorteJ.M., WahlstromT., AineR., HelleM., HelinH.: Steroid receptors and Ki-67 reactivity in ovarian cancer and in normal ovary: correlation with DNA flow cytometry, biochemical receptor assay, and patients survival.J. Pathol., 162: 295–301, 1990.
134.
IversenO.E.: Flow cytometric deoxyribonucleic acid index: a prognostic factor in endometrial carcinoma.Am. J. Obstet. Gynecol., 155: 770–776, 1986.
135.
IversenO.E.: Prognostic value of the flow cytometric DNA index in human ovarian carcinoma.Cancer, 61: 971–975, 1988.
136.
JakobsenA.: Prognostic impact of ploidy level in carcinoma of the cervix.Am. J. Clin. Oncol., 7: 475–480, 1984.
137.
JassJ.R., MukawaK., GohH.S., LoveS.B., CapellaroD.: Clinical importance of DNA content in rectal cancer measured by flow cytometry.J. Clin. Pathol., 42: 254–259, 1989.
JonesD.J., MooreM., SchofieldP.F.: Refining the prognostic significance of DNA ploidy status in colorectal cancer: a prospective flow cytometric study.Int. J. Cancer, 41: 206–210, 1988.
140.
KaczmarekL., CalabrettaB., BasergaR.: Expression of cell cycle dependent genes in phytohemagglutinin-stimulated human lymphocytes.Proc. Natl. Acad. Sci. USA, 82: 5375–5379, 1985.
141.
KaernJ., TropeC., KjorstadK.E., AbelerV., PettersenE.O.: Cellular DNA content as a new prognostic tool in patients with borderline tumors of the ovary.Gynecol. Oncol., 38: 452–457, 1990.
142.
KallioniemiO., PunnonenR., MattilaJ., LehtinenM., KoivulaT.: Prognostic significance of DNA index, multiploidy, and S-phase fraction.Cancer, 61: 334–339, 1988.
143.
KamataT., YonemuraY., SugiyamaK., OoyamaS., KosakaT., YamaguchiA., MiwaK., MiyazakiI.: Proliferative activity of early gastric cancer measured by in vitro and in vivo bromodeoxyuridine labeling.Cancer, 64: 1665–1668, 1989.
KapuscinskiJ., SkoczylasB.: Simple and rapid fluorimetric method for DNA microassay.Anal. Biochem., 83: 252–257, 1977.
146.
KarnJ., WatsonJ.V., LoweA.D., GreenS.M., VedeckisW.: Regulation of cell cycle duration by c-myc levels.Oncogene, 4: 773–787, 1989.
147.
KellyK., CocharnB.H., StilesC.D., LederP.: Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor.Cell, 35: 603–610, 1983.
148.
KhochbinS., ChabanasA., LawrenceJ.: Early events in murine erythroleukemia cells induced to differentiate: variation of the cell cycle parameters in relation to p53 accumulation.Exp. Cell Res., 179: 565–574, 1988.
149.
KhochbinS., PrincipaudE., ChabanasA., LawrenceJ.: Early events in murine erythroleukemia cells induced to differentiate: accumulation and gene expression of the transformation associated cellular protein p53.J. Mol. Biol., 200: 55–64, 1988.
150.
KimuraH., YonemuraY.: Flow cytometric analysis of nuclear DNA content in advanced gastric cancer and its relationship with prognosis.Cancer, 67: 2588–2593, 1991.
151.
KossL.G.: The puzzle of prostatic carcinoma.Mayo Clin. Proc., 63: 193–197, 1988.
152.
KossL.G., CzerniakB., HerzF., WerstoR.P.: Flow cytometric measurement of DNA and other cell components in human tumors: a critical appraisal.Hum. Pathol., 20: 528–548, 1989.
153.
KotyloP.K.: DNA analysis of neoplasia: an introduction for the family physician.Am. Fam. Physician., 43: 1259–1263, 1991.
154.
KreicbergsA., SilvferswärdC., TribukaitB.: Flow DNA analysis of primary bone tumors.Relationship between cellular DNA content and histopathologic classification. Cancer, 53: 129–136, 1984.
155.
KrissJ.P., ReveszL.: The distribution and fate of bromodeoxyuridine and bromodeoxycytidine in the mouse and rat.Cancer Res., 22: 254–265, 1961.
156.
KurkiP., VanderlaanM., DolbeareF., GrayJ., TanE.M.: Expression of proliferating cell nuclear antigen (PCNA)/cyclin during the cell cycle.Exp. Cell Res., 166: 209–219, 1986.
157.
KurkiK., OgataK., TanE.M.: Monoclonal antibodies to proliferating cell nuclear antigen (PCNA/cyclin) as probes for proliferating cells by immunofluorescence mycroscopy and flow cytometry.J. Immunol. Methods., 109: 49–59, 1988.
158.
LaerumO.D., FarsundT.: Clinical application of flow cytometry: a review.Cytometry, 2: 42–48, 1981.
159.
LangloisR.G., CarranoA.V., GrayJ.W., Van DillaM.A.: Cytochemical studies of metaphase chromosomes by flow cytometry.Chromosoma, 77: 229–252, 1980.
160.
LangloisR.G., YuL.C., GrayJ.W., CarranoA.V.: Quantitative karyotyping of human chromosomes by dual beam flow cytometry.Proc. Natl. Acad. Sci. USA, 79: 7876–7880, 1982.
161.
LarsenJ.K., Munch-PetersonB., ChristansenJ., JorgensenK.: Flow cytometric discrimination of mitotic cells: resolution of M, as well as G1, S and G2 phase nuclei with mithramycin, propidium iodide, and ethidium bromide after fixation with formaldehyde.Cytometry, 7: 54–63, 1986.
162.
LarsenK.: Washless double-staining of a nuclear antigen (Ki67 or BrdU) and DNA in unifixed nuclei. In: DarzynkiewiczZ., CrissmanH.A. (Eds.), Methods in Cell Biology. Vol. 33 Flow Cytometry.Academic Press, New York, U.S.A., 1990.
163.
LevineD.S., ReidB.J., HaggittR.C., RubinC.E., RabinovitchP.S.: Correlation of ultrastructural aberrations with dysplasia and flow cytometric abnormalities in Barrett's epithelium.Gastroenterology, 96: 355–367, 1989.
164.
LevineA.J., MomandJ.: Tumor suppressor genes: the p53 and retinoblastoma sensitivity genes and gene products.Biochem. Biophys. Acta, 1032: 119–136, 1990.
165.
LiuE., HjelleB., MorganR., HechtF., BishopM.: Mutations of the kirsten-ras proto-oncogene in human preleukemia.Nature, 300: 186–188, 1987.
166.
LjungbergB., StenlingR., RoosG.: Prognostic value of deoxyribonucleic acid content in metastatic renal cell carcinoma.J. Urol., 136: 801–804, 1986.
167.
LjunbergB., NordensonI., RoosG.: Cytogenetic and flow cytometric DNA analysis in renal cell carcinoma.Eur. Urol., 19: 59–64, 1991.
168.
LöfbergR., TribukaitB., OestA., BroströmO., ReichardH.: Flow cytometric DNA analysis in longstanding ulcerative colitis: a method of prediction of dysplasia and carcinoma development?Gut, 28: 1100–1106, 1987.
169.
LookA.T., DouglasE.C., MeyerW.H.: Clinical importance of near-diploid tumor stem lines in patients with osteosarcoma of an extremity.N. Engl. J. Med., 318: 1567–1572, 1988.
170.
LovettE.J., SchnitzerB., KerenD.F., FlintA., HudsonJ.L., McClatcheyK.D.: Application of flow cytometry to diagnostic pathology.Lab. Invest., 50: 115–140, 1984.
LundbergS., CarstensenJ., RundquistI.: DNA flow cytometry and histopathological grading of paraffin-embedded prostate biopsy specimens in a survival study.Cancer Res., 47: 1973–1977, 1987.
173.
LundyJ., GrimsonR., MishrikiY., ChaoS., OravezS., FromowitzF., ViolaM.V.: Elevated ras oncogene expression correlates with lymph node metastasis in breast cancer patients.J. Clin. Oncol., 4: 1321–1325, 1986.
174.
MathewsM.B., BernsteinR.M., FranzaR.B.Jr.: Identify of the proliferating cell nuclear antigen and cyclin.Nature, 309: 374–376, 1984.
175.
McDivittR.W., StoneK.R., CraigR.B., MeyerJ.S.: A comparison of human breast cancer cell kinetics measured by flow cytometry and thymidine labeling.Lab. Invest., 52: 287–291, 1985.
176.
McGrathJ.P., CaponD.J., GoeddelD.V., LevinsonA.D.: Comparative properties of normal and activated human ras p21 protein.Nature, 310: 644–649, 1984.
177.
McGuireW.L., DressierL.G.: The emerging impact of flow cytometry in predicting recurrence and survival in breast cancer: a review.J. Natl. Cancer Inst., 75: 405–410, 1985.
178.
McGuireW.L., MeyerJ.S., BarlogieB., KuteT.E.: Impact of flow cytometry on predicting recurrence and survival in breast cancer patients.Breast Cancer Res. Treat., 5: 117–128, 1985:
MelamedM.R.: Flow cytometry detection and evaluation of bladder tumors.J. Occup. Med., 32: 829–833, 1990.
181.
MelamedM.R., MullaneyP.F., ShapiroH.M.: An historical review of the development of flow cytometers and sorters. In: MelamedM.R., LindmoT., MendelsohnM.L. (Eds.), Flow Cytometry and Sorting.Wiley-Liss, New York, U.S.A., 1–10, 1990.
182.
MelamedM.R., Staiano-CoicoL.: Flow cytometry in clinical cytology. In: MelamedM.R., LindmoT., MendelsohnM.L. (Eds.), Flow Cytometry and Sorting.Wiley-Liss, New York, U.S.A., 755–772, 1990.
183.
MellinW.: Cytophotometry in tumor pathology.A critical review of methods and applications, and some results of DNA analysis. Pathol. Res. Pract., 186: 37–62, 1990.
184.
MelvilleD.M., JassJ.R., ShepherdN.A., NorthoverJ.M.A., CapellaroD., RichmanP.I., Lennard-JonesJ.E., RitchieJ.K., AndersenS.N.: Dysplasia and deoxyribonucleic acid aneuploidy in the assessment of precancerous changes in chronic ulcerative colitis.Gastroenterology, 95: 668–675, 1988.
185.
MercerW.E., AvignoloC., BasergaR.: Role of p53 protein in cell proliferation as studied by microinjection of monoclonal antibodies.Mol. Cell. Biol., 4: 276–281, 1984.
186.
MercerW.E., ShieldsM.T., AminM., SauveG.J., AppellaE., RomanoJ.W., UllrichS.J.: Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53.Proc. Natl. Acad. Sci. USA, 87: 6166–6170, 1990.
187.
MerkelD.E., DressierL.G., McGuireW.L.: Flow cytometry, cellular DNA content, and prognosis in human malignancy.J. Clin. Oncol., 5: 1690–1703, 1987.
188.
MerkelD.E., McGuireW.: Ploidy, proliferative activity and prognosis.Cancer, 65: 1194–1205, 1990.
189.
MervakT., FlintA., SchnitzerB.: Flow cytometric DNA analysis of non-Hodgkin's lymphomas: determination of ploidy of fresh and paraffin embedded tissues.Lab. Invest., 54: 43A, 1986.
190.
MiyachiK., FritzlerM.J., TanE.M.: Autoantibody to a nuclear antigen in proliferating cells.J. Immunol., 121: 2228–2234, 1978.
191.
MulcahyL.S., SmithM.R., StaceyD.W.: Requirement for ras proto-oncogene function during serum-stimulated growth of NIH 3T3 cells.Nature, 313: 241–244, 1985.
MurrayA.W.: The cell cycle as a cdc2 cycle.Nature, 342: 14–15, 1989.
194.
NagashimaT., De ArmondS.J., MurovicJ., HoshinoT.: Immunocytochemical demonstration of S-phase cells by anti-bromodeoxyuridine monoclonal antibody in human brain tumor tissues.Acta Neuropathol., 67: 155–159, 1985.
195.
NagashimaT., HoshinoT., ChoK.G., SenegorM., WaldmanF., NomuraK.: Comparison of bromodeoxyuridine labeling indices obtained from tissue sections and flow cytometry of brain tumors.J. Neurosurg., 68: 388–392, 1988.
196.
NemotoR., HattoriK., UchidaK., ShimazuiT., NishijimaY., KoisoK., HaradaM.: S-phase fraction of human prostate adenorcarcinoma studied with in vivo bromodeoxyuridine labeling.Cancer, 66: 509–514, 1990.
197.
NomoriH., HirohashiS., NoguchiM., MatsunoY., ShimosatoY.: Tumor cell heterogeneity and subpopulations with metastatic ability in differentiated adenocarcinoma of the lung.Histologic and cytofluorimetric DNA analyses. Chest., 99: 934–940, 1991.
198.
NowellP., HungerfordD.A.: A minute chromosome in human granulocytic leukemia.Science, 132: 1497–1499, 1960.
199.
NowellP.C.Molecular events in tumor development.N. Engl. J. Med., 319: 575–577, 1988.
200.
NowellP.C.: Chromosomal and molecular clues to tumor progression.Semin. Oncol., 16: 116–127, 1989.
201.
NowellP.C.: Cytogenetics of tumor progression.Cancer, 655: 2172–2177, 1990.
202.
NüsseM., JülchM., GeidoE., BrunoS., Di VinciA., GiarettiW., RuossK.: Flow cytometric detection of mitotic cells using the BrdU/DNA technique in combination with 90° and forward scatter measurements.Cytometry, 10: 312–319, 1989.
203.
OgataK., KurkiP., CelisJ.E., NakamuraR.M., TanE.M.: Monoclonal antibodies to a nuclear protein (PCNA/cyclin) associated with DNA replication.Exp. Cell Res., 168: 475–480, 1987.
204.
OhyamaS., YonemuraY., MiyazakiI.: Prognostic value of S-phase fraction and DNA ploidy studied with in vivo administration of bromodeoxyuridine on human gastric cancers.Cancer, 65: 116–121, 1990.
205.
OlahE., EzerR., GiarettiW., EbleJ.: Metabolic control of oncogene expression.Biochem. Transact., 18: 72–74, 1990.
206.
OrenM.: p53: Molecular properties and biological activities. In: KahnP., GrafT. (Eds.), Oncogenes and Growth Control.Berlin: Springer-Verlag, 284–289, 1986.
207.
OttoF.J., OldigesH., GöhdeW., JainV.K.: Flow cytometric measurement of nuclear DNA content variations as a potential in vivo mutagenicity test.Cytometry, 2: 189–191, 1981.
208.
OttoF.: Dapi staining of fixed cells for high-resolution flow cytometry of nuclear DNA.Methods Cell Biol., 33: 105–119, 1990.
Pederson-BjergaardJ., JanssenJ.W.G., LyonsJ.J., PhilipP., BartramC.R.: Point mutation of the ras protooncogenes and chromosome aberrations in acute nonlymphocytic leukemia and preleukemia related to therapy with alkilating agents.Cancer Res., 48: 1812–1817, 1988.
211.
PersonH., LederP.: Nuclear localization and DNA binding properties of a protein expressed by human c-myc oncogene.Science, 225: 718–721, 1984.
212.
PetersenS.E., LorentzenM., BichelP.: A mosaic subpopulation structure of human colorectal carcinomas demonstrated by flow cytometry.Flow CytometryIV, 412–416, 1980.
213.
PfefferU., VidaliG.: A novel protein related to cell cycle-dependent alterations of chromatin structure.Exp. Cell Res., 193: 411–419, 1991.
214.
PfefferU., Di VinciA., GeidoE., VidaliG., GiarettiW.: Cell cycle dependent alterations of chromatin structure in situ as revealed by the accessibility of the nuclear protein AF-2 to monoclonal antibodies.J. Cell. Physiol., 1991 (in press).
215.
PientaK.J., PartinA.W., CoffeyD.S.: Cancer as a disease of DNA organization and dynamic cell structure.Cancer Res., 49: 2525–2532, 1989.
216.
Ponz de LeonM., RoncucciL., Di DonatoP., TassiL., SmerieriO., AmoricoM.G., MalagoliG., De MariaD., AntonioliA., ChahinN.J., PeriniM., RigoG., BarberiniG., ManentiA., BiascoG., BarbaraL.: Pattern of epithelial cell proliferation in colorectal mucosa of normal subjects and of patients with adenomatous polyps or cancer of the large bowel.Cancer Res., 48: 4121–4126, 1988.
217.
PrelichG., TanC.K., KosturaM., MathewsM.B., DowneyK.M., StillmanB.: Functional identify of proliferating cell nuclear antigen and DNA polymerase-δ auxiliary protein.Nature, 326: 517–520, 1987.
ProkocimerM., ShaklaiM., Ben BassatH., WolfD., GoldfingerN., RotterV.: Expression of p53 in human leukemia and lymphoma.Blood, 68: 113–118, 1986.
220.
QuirkeP., FozardJ.B.J., DixonM.F., DysonJ.E.D., GilesG.R., BirdC.C.: DNA aneuploidy in colorectal adenomas.Br. J. Cancer, 53: 477–481, 1986.
221.
RabbittsP.H., WatsonJ.V., LamondA., ForsterA., StinsonM.A., EvanG., FischerW., AthertonE., SheppardR., RabbittsT.H.: Metabolism of c-myc gene products: c-myc mRNA and protein expression in the cell cycle.EMBO, 4: 2009–2015, 1985.
222.
RaberM.N., BarlogieB.: DNA flow cytometry of human solid tumors. In: MelamedM.R., LindmoT., MendelsohnM.L. (Eds.), Flow Cytometry and Sorting.Wiley-Liss, New York, U.S.A., 745–754, 1990.
223.
RalfkiaerE., SteintlB.J., GatterK.C., RalfkiaerN., WantzinG.L., MasonD.Y.: Expression of a cell cycle-associated nuclear antigen (Ki67) in cutaneous lymphoid infiltrates.Am. J. Dermatol., 8: 37–43, 1986.
224.
RemvikosY., Laurent-PuigP., SalmonR.J., FrelatG., DutrillauxB., ThomasG.: Simultaneous monitoring of p53 protein and DNA content of colorectal adenocarcinomas by flow cytometry.Int. J. Cancer, 45: 450–456, 1990.
225.
RiccardiA., DanovaM., WilsonG., UcciG., DörmerP., MazziniG., BrugnatelliS., GirinoM., McNallyN.J., AscariE.: Cell kinetics in human malignancies studied with in vivo administration of bromodeoxyuridine and flow cytometry.Cancer Res., 48: 6238–6245, 1988.
226.
RiversJ.K., KopfA.W., VinokurA.F., RigelD.S., FriedmanR.J., HeilmanE.R., LevensteinM.: Clinical characteristics of malignant melanomas developing in persons with dysplastic nevi.Cancer, 65: 1232–1236, 1990.
227.
RosetteC.D., De TeresaP.S., PallaviciniM.G.: Simultaneous flow cytometric detection of cellular c-myc protein, incorporated bromodeoxyuridine, and DNA.Cytometry, 11: 547–551, 1990.
228.
RutegardJ., StelingR.: DNA content in ulcerative colitis.Hepato-Gastroenterol., 36: 205–208, 1989.
229.
RyanD.H., FallonM.A., HoranP.K.: Flow cytometry in the clinical laboratory.Clin. Chim. Acta, 171: 125–173, 1988.
230.
SasakyK., MurakamiT., KawasakiM., TakahashiM.: The cell cycle associated change of the Ki67 reactive nuclear antigen expression.J. Cell. Physiol., 133: 578–584, 1987.
231.
SchutteB., ReyndersM.M.J., BosmanF.T., BlijhamG.H.: Flow cytometric determination of DNA ploidy level in nuclei isolated from paraffin-embedded tissue.Cytometry, 6: 26–30, 1985.
232.
SchutteB., ReyndersM.M.J., van AsscheC.L.M.V.J., HupperetsP.S.G.J., BosmanF.T., BlijhamG.H.: An improved method for the immunocytochemical detection of bromodeoxyuridine labeled nuclei using flow cytometry.Cytometry, 8: 372–376, 1987.
233.
SchwartingK., GerdesJ., NiehusJ., JaeskeL., SteinH.: Determination of the growth fraction in cell suspensions by flow cytometry using the monoclonal antibody Ki67.J. Immunol, Meth., 90: 65–701986.
234.
ScialleroS., BrunoS., Di VinciA., GeidoE., AsteH., GiarettiW.: Flow cytometric DNA ploidy in colorectal adenomas and family history of colorectal cancer.Cancer, 61: 114–120, 1988.
235.
ShaabanA.A., TribukaitB., BedeiwyA.F., GhoneimM.A.: Characterization of squamous cell bladder tumors by flow cytometric deoxyribonucleic acid analysis: a report of 100 cases.J. Urol., 144: 879–883, 1990.
236.
ShapiroH.M.: Multistation multiparameter flow cytometry: a critical review and rationale.Cytometry, 3: 227–243, 1983.
237.
ShapiroH.K.: Practical Flow Cytometry (second edition).Wiley-Liss, New York, U.S.A., 1988.
238.
ShihT.Y., WeeksM.O.: Oncogenes and cancer: the p21 ras genes.Cancer Invest., 2: 109–123, 1984.
239.
SilvestriniR., DaidoneM.G., ValagussaP., Di FronzoG., MezzanotteG., BonadonnaG.: Cell kinetics as a prognostic indicator in node-negative breast cancer.Eur. J. Cancer Clin. Oncol., 25: 1165–1171, 1989.
240.
SmeetsA.W.G.B., PauwelsR.P.E., BeckJ.L.M., GeradtsJ.P.M., DebruyneF.M.J., LaarakkersL., FeitzW.F.J., VooijsG.P., RamaekersF.C.S.: Tissue-specific markers in flow cytometry of urological cancers III.Comparing chromosomal and flow cytometric DNA analysis of bladder tumors. Int. J. Cancer, 39: 304–310, 1987.
241.
SondergaardK., LarsenJ.K., MollerU., ChristensenI.J., Hou-JensenK.: DNA ploidy-characteristics of human malignant melanoma analysed by flow cytometry and compared with histology and clinical course.Virchows Arch. (Cell. Pathol.), 42: 43–52, 1983.
242.
SongJ., FarrowG.M., LieberM.M.: Primary adenocarcinoma of the bladder: favorable prognostic significance of deoxyribonuceic acid diploidy measured by flow cytometry.J. Urol., 144: 1115–1118, 1990.
243.
SpaarF.W., BlechM., AhyaiA.: DNA-flow fluorescence-cytometry of ependymomas.Report on ten surgically removed tumors. Acta Neuropathol. (Berl), 69: 153–160, 1986.
244.
SteenH.B.: Characteristics of flow cytometers. In: MelamedM.R., LindmoT., MendelsohnM.L. (Eds.), Flow Cytometry and Sorting.Wiley-Liss, New York, U.S.A., 11–26, 1990.
StenkvistB., Olding-StenkvistE.: Cytological and DNA characteristics of hyperplasia/inflammation and cancer of the prostate.Eur. J. Cancer, 26: 261–267, 1990.
247.
StudzinskiG.P.: Oncogenes, growth, and the cell cycle: an overview.Cell Tissue Kinet., 22: 405–424, 1989.
248.
TakasakiY., FishwildD., TanE.M.: Characterization of proliferating cell nuclear antigen recognized by autoantibodies in lupus sera.J. Exp. Med., 159: 981–982, 1984.
249.
TeodoriL., CapursoL., CordelliE., De VitaR., KochM., TarquiniM., PalloneF., MauroF.: Cytometrically determined relative DNA content as an indicator of neoplasia in gastric lesions.Cytometry, 5: 63–70, 1984.
250.
TeodoriL., TrincaM.L., GöhdeW., HemmerJ., SalvatiF., StornielloG., MauroF.: Cytokinetic investigation of lung tumors using the anti-bromodeoxyuridine (BUdR) monoconal antibody method: comparison with DNA flow cytometric data.Int. J. Cancer, 45: 995–1001, 1990.
251.
ThorA., HoranH.P., WunderlichD., CarusoA., MuraroR., SchlomJ.: Monoclonal antibodies define different ras gene expression in malignant and benign colonic disease.Nature, 311: 562–565, 1984.
252.
ThornthwaiteJ.T., SugarbakerE.V., TempleW.J.: Preparation of tissue for DNA flow cytometric analysis.Cytometry, 1: 229–237, 1980.
253.
Tirindelli-DanesiD., TeodoriL., MauroF., ModiniC., BottiC., CicconettiF., StipaS.: Prognostic significance of flow cytometry in lung cancer.Cancer, 60: 844–851, 1987.
254.
TraganosF.: Single- and multiparameter analysis of the effects of chemotherapeutic agents on cell proliferation in vitro. In: MelamedM.R., LindmoT., MendelsohnM.L. (Eds.), Flow Cytometry and Sorting.Wiley-Liss, New York, U.S.A., 773–802, 1990.
255.
TribukaitB., HammarbergC., RubioC.: Ploidy and proliferation patterns in colorectal adenocarcinomas related to Dukes’ classification and to histopathological differentiation.Acta Pathol. Microbiol. Immunol. Scand. Sect. A, 91: 89–95, 1983.
256.
TribukaitB.: Flow cytometry in surgical pathology and cytology of tumors of the genito-urinary tract. In: KossL.G., ColemanD.V. (Eds.), Advances in Clinical Cytology, Masson, New York, vol. 2, 163–189, 1984.
257.
TribukaitB.: Flow cytometry in assessing the clinical aggressiveness of genito-urinary neoplasms.World J. Urol., 5: 108–122, 1987.
TsuchiyaH., EpsteinJ., SelvanayagamP., DedmanJ.R., GallikG., AlexanianR., BarlogieB.: Correlated flow cytometric analysis of H-ras p21 and nuclear DNA in multiple myeloma.Blood, 72: 796–800, 1988.
260.
van BockstaeleD.R., LanJ., SnoeckH.W., KorthoutM.L., De BockR.F., PeetermansM.E.: Aberrant Ki-67 expression in normal bone marrow revealed by multiparameter flow cytometric analysis.Cytometry, 12: 50–63, 1991.
261.
van den EnghG., TraskB., CramS., BartholdiM.: Preparation of chromosome suspensions for flow cytometry.Cytometry, 5: 108–117, 1984.
262.
van den EnghG., TraskB., LandsdorpP., GrayJ.W.: Improved resolution of flow cytometric measurements of Hoechst-chromomycin-stained human chromosomes after addition of citrate and sulfite.Cytometry, 9: 266–270, 1988.
263.
van den InghH.F., GriffioenG., CornelisseC.J.: Flow cytometric detection of aneuploidy in colorectal adenomas.Cancer Res., 45: 3392–3397, 1985.
264.
VindelovL.L., ChristensenI.J., JensenG., NissenN.I.: Limits of detection of nuclear DNA abnormalities by flow cytometric DNA analysis.Results obtained from a set of methods for sample-storage, staining and internal standardization. Cytometry, 3: 332–339, 1983.
265.
VindelovL.L., ChristensenI.J., KeidingN., Spang-ThomsenM., NissenN.I.: Long-term storage of samples for flow cytometric DNA analysis.Cytometry, 3: 317–322, 1983.
266.
VindelovL.L., ChristensenI.J.: A review of techniques and results obtained in one laboratory by an integrated system of methods designed for routine clinical flow cytometric DNA analysis.Cytometry, 11: 753–770, 1990.
267.
ViolaM.V., FromowitzF., OravezS., DebS., SchlomJ.: Ras oncogene p21 expression is increased in premalignant lesions and high grade bladder carcinoma.J. Exp. Med., 161: 1213–1218, 1985.
268.
ViolaM.V., FromowitzF., OvarezS., DebS., FinkelJ., LundyJ., HoranH.P., ThorA., SchlomJ.: Expression of ras oncogene p21 in prostate cancer.N. Engl. J. Med., 314: 133–137, 1986.
VolmM., MatternJ., SonkaJ., Vogt-SchadenM., WayssK.: DNA distribution in non-small cell lung carcinomas and its relationship to clinical behavior.Cytometry, 6: 348–356, 1985.
271.
VolpeJ.P.G.: Genetic instability of cancer: why a metastatic tumor is unstable and a benign tumor is stable.Cancer Genet. Cytogenet., 34: 125–134, 1988.
272.
WangE.: A 57,000 mol wt protein uniquely present in nonproliferating cells and senescent human fibroblasts.J. Cell Biol., 100: 545–551, 1985.
273.
WangE.: Rapid dissapearance of statin a nonproliferating and senescent cell-specific protein upon reentering the process of cell cycling.J. Cell Biol., 101: 1695–1701, 1985.
274.
WangE., KruegerJ.G.: Application of a unique monoclonal antibody as a marker for nonproliferating subpopulations of cells of some tissue.J. Histochem. Cytochem., 33: 587–594, 1985.
275.
WatsonJ.V., SikoraK., EvanG.I.: A simultaneous flow cytometric assay for c-myc oncoprotein and DNA in nuclei from paraffin embedded material.J. Immunol. Methods, 83: 179–192, 1985.
276.
WatsonJ.V.: Oncogenes, cancer and analytical cytology.Cytometry, 7: 400–410, 1986.
277.
WeinbergR.A.: The action of oncogenes in the cytoplasm and the nucleus.Science, 230: 770–776, 1985.
278.
WheelessL.L., KayD.B.: Optics, light sources, filters, and optical systems. In: Van DillaM.A., DeanP.N., LaerumO.D., MelamedM.R. (Eds.), Flow Cytometry: Instrumentation and Data AnalysisAcademic Press, London, New York Tokyo, 21–76, 1985.
279.
WhiteR.A., MeistrichM.L.: A comment on « A method to measure the duration of DNA synthesis and the potential doubling time from a single sample ».Cytometry, 7: 486, 1986.
280.
WickstromE.L., BaconT.A., GonzalezA., FreemanD.L., LymanG.H., WickstromE.: Human promyelocytic leukemia HL-60 cell proliferation and c-myc protein expression are inhibited by antisense pentacadeoxynucleotide targeted against c-myc mRNA.Proc. Natl. Acad. Sci. USA, 85: 1028–1032, 1988.
281.
WilliamsN.N., DalyJ.M.: Flow cytometry and prognostic implications in patients with solid tumors.Surg. Gynecol. Obstet., 171: 257–266, 1990.
282.
WilsonG.D., McNallyN.J., DunphyE., KaercherH., PfrangerR.: The labelling index of human and mouse tumors assessed by bromodeoxyuridine staining in vitro and in vivo and flow cytometry.Cytometry, 6: 641–647, 1985.
283.
WilsonG.D., SoransonJ.A., LewisA.A.: Cell kinetics of mouse kidney using bromodeoxyuridine incorporation and flow cytometry: Preparation and staining.Cell Tissue Kinet., 20: 125–133, 1987.
284.
WilsonG.D., McNallyN.J., DischeS., SaundersM.I., Des RochersC., LewisA.A., BennettM.H.: Measurement of cell kinetics in human tumors in vivo using bromodeoxyuridine incorporation and flow cytometry.Br. J. Cancer, 58: 423–431, 1988.
285.
YamaguchiA., IshidaT., TakegawaS., NishimuraG., KannoM., KosakaT.: Flow-cytometric analysis of colorectal cancer with hepatic metastases and its relationship to metastatic characteristics and prognosis.Oncology, 47: 478–482, 1990.
286.
YonemuraY., OoyamaS., SugiyamaK., KamataT., De AretxabalaX., KimuraH., KosakaT., YamaguchiA., MiwaK., MiyazakiI.: Retrospective analysis of the prognostic significance of DNA ploidy patterns and S-phase fraction in gastric carcinoma.Cancer Res., 50: 509–514, 1990.
287.
YoungB.D., Ferguson-SmithM.A., SillarR., BoydeE.: High resolution analysis of human peripheral lymphocyte chromosomes by flow cytometry.Proc. Natl. Acad. Sci. USA, 78: 7727–7731, 1981.
288.
ZapryanovZ., ChristovK.: Histological grading, DNA content, cell proliferation, and survival of patients with astroglial tumors.Cytometry, 9: 380–386, 1988.
289.
ZarboR.J., VisscherD.W., CrissmanJ.D.: Two-color multiparametric method for flow cytometric DNA analysis of carcinomas using staining for cytokeratin and leukocytecommon antigen.Anal. Quant. Cytol. Histol., 11: 391–402, 1989.
290.
ZuckerR.M., ElsteinK.H., EasterlingR.E., MassaroE.J.: Flow cytometric discrimination of mitotic nuclei by right-angle light scatter.Cytometry, 9: 226–231, 1988.
